• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多价超免疫球蛋白可预防人巨细胞病毒对单核细胞类型细胞的感染]

[Polyvalent hyperimmune immunoglobulins prevent the infection of monocytic type cells by human cytomegalovirus].

作者信息

Delannoy A S, Hober D, Bouzidi A, Lobert P E, Wattré P

机构信息

Laboratoire de Virologie, CHRU, bâtiment IRFPPS, Lille, France.

出版信息

Pathol Biol (Paris). 1996 May;44(5):461-3.

PMID:8758495
Abstract

Monocyte/macrophage cell types can be infected with Human Cytomegalovirus (HCMV) could be a reservoir and a vehicle for virus spread in infected patients. We developed a model to study the effects of antiviral molecules on these cells. The monocytic-like cell line THP-1 and the human diploïd cells MRC-5 were used. THP-1 cells were cultivated with a phorbol 12-myristate 13-acetate (PMA) for 24h prior to the infection. We studied infection of these cells with reference strain (AD-169). A cell free virus suspension of HCMV was preincubated with hyperimmune polyvalent immunoglobulins. The infection of the cells was studied on the basis of immune detection of viral immediate early antigens (IEA) in nucleus 24h after culture. Our results showed that hyperimmune polyvalent immunoglobulins have been able to neutralize fibroblasts and THP-1 cells infection, whereas control antibodies did not inhibit the infection of the cells. This is the first report of the use of monocytic-like cells for testing the efficiency of anti-CMV molecules.

摘要

单核细胞/巨噬细胞类型可被人巨细胞病毒(HCMV)感染,可能是病毒在感染患者体内的储存库和传播载体。我们建立了一个模型来研究抗病毒分子对这些细胞的影响。使用了单核细胞样细胞系THP-1和人二倍体细胞MRC-5。在感染前,THP-1细胞用佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)培养24小时。我们用参考毒株(AD-169)研究了这些细胞的感染情况。将HCMV的无细胞病毒悬液与超免疫多价免疫球蛋白预孵育。在培养24小时后,基于对细胞核中病毒即刻早期抗原(IEA)的免疫检测来研究细胞的感染情况。我们的结果表明,超免疫多价免疫球蛋白能够中和成纤维细胞和THP-1细胞的感染,而对照抗体则不能抑制细胞的感染。这是首次使用单核细胞样细胞来测试抗CMV分子效率的报告。

相似文献

1
[Polyvalent hyperimmune immunoglobulins prevent the infection of monocytic type cells by human cytomegalovirus].[多价超免疫球蛋白可预防人巨细胞病毒对单核细胞类型细胞的感染]
Pathol Biol (Paris). 1996 May;44(5):461-3.
2
A macrophage-like cell model for testing anti-CMV drugs.
Pathol Biol (Paris). 1997 May;45(5):394-9.
3
Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.人巨细胞病毒趋化因子受体基因US28在潜伏感染的THP-1单核细胞中被转录。
J Virol. 2001 Jul;75(13):5949-57. doi: 10.1128/JVI.75.13.5949-5957.2001.
4
Role of interferon alpha (IFN-alpha) and interferon gamma (IFN-gamma) in the control of the infection of monocyte-like cells with human cytomegalovirus (HCMV).α干扰素(IFN-α)和γ干扰素(IFN-γ)在控制人巨细胞病毒(HCMV)感染单核细胞样细胞中的作用。
Microbiol Immunol. 1999;43(12):1087-96. doi: 10.1111/j.1348-0421.1999.tb03365.x.
5
Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.反义寡核苷酸对人视网膜上皮细胞模型中人类巨细胞病毒复制的抑制作用
Invest Ophthalmol Vis Sci. 2001 Jan;42(1):163-9.
6
Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line.在单核细胞系的裂解性感染和潜伏感染期间,通过差异组蛋白修饰对人巨细胞病毒基因表达的调控
Gene. 2006 Dec 15;384:120-8. doi: 10.1016/j.gene.2006.07.021. Epub 2006 Jul 31.
7
Inhibitory effect of povidone-iodine for the antigen expression of human cytomegalovirus.聚维酮碘对人巨细胞病毒抗原表达的抑制作用。
In Vivo. 1999 May-Jun;13(3):239-41.
8
[Productive replication of human cytomegalovirus in primary microglial cells].[人巨细胞病毒在原代小胶质细胞中的有效复制]
Pathol Biol (Paris). 1998 Jun;46(6):426-30.
9
Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.持续性人巨细胞病毒感染可诱导人神经母细胞瘤细胞产生耐药性并改变程序性细胞死亡。
Cancer Res. 1998 Jan 15;58(2):367-72.
10
Cytomegalovirus infection after orthotopic liver transplantation is restricted by a pre-existing antiviral immune response of the recipient.
J Med Virol. 2004 May;73(1):45-53. doi: 10.1002/jmv.20060.